ODIN Biotech Partners

Healthcare 📍 Dallas, United States 👥 11-50 employees 💰 $600K raised 📅 Founded 2014

ODIN Biotech Partners, LLC is a development-stage biotechnology company focused on developing novel peptide therapeutics for diseases of the retina. ODIN’s lead product, C16Y, is currently in preclinical development for the treatment of wet age-related macular degeneration (AMD). ODIN expects to begin clinical studie

🌐 Website ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

11-50

Total Raised · Venture

$600K

Founded

2014

Cloud

Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	🔒 Subscribers only
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from ODIN Biotech Partners's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction